Thursday, 9 September, 2021

About this event
Scotland has set itself the ambitious target of effective elimination of hepatitis C by 2024. In line with this, an eclectic assembly of care pathways are being developed throughout the country, with the aim of improving access to hep C testing and treatment. Many of these pathways are community-based, collocated into existing drug services, community pharmacies, homeless services and needle exchanges. Outreach clinics in GP surgeries have also proved to be valuable, but the role of primary care and general practitioners in initiating hep C treatment has received less attention to date.

A team of researchers have been exploring the potential for GP-initiated hep C treatment in Scotland, and thinking about what it might look like and how it could work. In this meeting they’ll share their findings, presenting a theory-informed treatment pathway and suggestions for how it could be implemented. They’ll also be keen to hear what you think.

This meeting is for anyone with an interest in hepatitis C and its treatment.

Dr Dave Whiteley is a lecturer at Glasgow Caledonian University, and has been working with Elizabeth Speakman (Edinburgh Napier University), Prof Lawrie Elliott (GCU), Prof Paul Flowers (University of Strathclyde), Dr Helen Jarvis (GP, University of Newcastle & RCGP Clinical Champion for Liver Disease), Katherine Davidson (Advanced Clinical Pharmacist, NHS Lothian), Dr Mike Quinn (GP, Craigmillar Medical Group, Edinburgh) and the Scottish Drugs Forum. This research was funded by the Chief Scientist Office of the Scottish Government (HIPS/18/49).

To register visit: